Calidi Biotherapeutics, Inc. Common Stock (CLDI)
0.9980
-0.0020 (-0.20%)
NYSE · Last Trade: Jul 11th, 4:17 AM EDT
Via Benzinga · July 10, 2025
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · July 10, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via Chartmill · July 10, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active stocks in today's session.
Via Chartmill · July 10, 2025
Via Benzinga · July 10, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · July 10, 2025
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · July 10, 2025
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · July 9, 2025
Get a pulse on the US markets on Wednesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Via Chartmill · July 9, 2025
Via Benzinga · July 9, 2025
Via Benzinga · July 9, 2025
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · July 9, 2025
Via Benzinga · July 9, 2025
U.S. stock futures advanced on Wednesday after ending on a mixed note on Tuesday. Futures of major benchmark indices were trading higher.
Via Benzinga · July 9, 2025
Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover interest.
Via Benzinga · July 9, 2025
Calidi Biotherapeutics (NYSE: CLDI) surged 39.47% after hours Tuesday, following renewed investor interest in its innovative cancer treatment developments.
Via Benzinga · July 9, 2025
Via Benzinga · July 8, 2025
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · June 23, 2025
Via Benzinga · June 13, 2025

Via Benzinga · June 3, 2025
Via Benzinga · April 21, 2025

The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · February 19, 2025

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · February 5, 2025

Calidi Biotherapeutics shares are trading lower by 32% during Friday's session. The company priced its public offering of 5 million shares of common stock at $0.85 per share.
Via Benzinga · January 10, 2025